year
Category: | Intermediates/Pharmaceutical intermediates |
|
|
CAS NO: | 108341-18-0;69815-49-2 | ||
EC NO: | 211-268-5 | ||
Molecular Formula: | C12H19NO10 | ||
Molecular Weight: | 337.28 | ||
Specification: | |||
InChI: | InChI=1/C8H11NO3.C4H6O6.H2O/c9-4-8(12)5-1-2-6(10)7(11)3-5;5-1(3(7)8)2(6)4(9)10;/h1-3,8,10-12H,4,9H2;1-2,5-6H,(H,7,8)(H,9,10);1H2/t8-;1-,2-;/m01./s1 | ||
Synonyms: | (R)-()-Norepinephrine L-bitartrate monohydrate;norepinephrine hydrogen tartrate monohydrate;norepinephrine bitartrate monohydrate*200 mg per;(-)-arterenol bitartrate hydrate;1,2-Benzenediol, 4-(2-amino-1-hydroxyethyl)-, (R)-(R-(R*,R*))-2,3-dihydroxybutanedioate (1:1) (salt), monohydrate;4-[(1R)-2-amino-1-hydroxyethyl]benzene-1,2-diol 2,3-dihydroxybutanedioate hydrate (salt);Noradrenaline Bitartrate monohydrate;L-4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol bitartrate;Noradrenaline Bitartrate; | ||
Molecular Structure: |